Trevi Therapeutics (NASDAQ:TRVI) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners began coverage on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research report released on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $7.00 price objective on the stock. Other research analysts also recently issued research reports about the company. Rodman & Renshaw began coverage on Trevi […]
More Stories
Vanguard Industrials ETF (NYSEARCA:VIS) Sees Unusually-High Trading Volume – Should You Buy?
Vanguard Industrials ETF (NYSEARCA:VIS – Get Free Report) saw an uptick in trading volume on Wednesday . 363,169 shares were...
UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by MRA Advisory Group
MRA Advisory Group trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 10.4% in the...
The Scotts Miracle-Gro Company (NYSE:SMG) Sees Significant Decrease in Short Interest
The Scotts Miracle-Gro Company (NYSE:SMG – Get Free Report) was the target of a significant drop in short interest in...
Citigroup Target of Unusually Large Options Trading (NYSE:C)
Citigroup Inc. (NYSE:C – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors acquired...
Short Interest in GraniteShares 2x Long MSFT Daily ETF (NASDAQ:MSFL) Decreases By 21.7%
GraniteShares 2x Long MSFT Daily ETF (NASDAQ:MSFL – Get Free Report) saw a significant drop in short interest during the...
Franchise Brands (LON:FRAN) Reaches New 12-Month Low – Here’s Why
Shares of Franchise Brands plc (LON:FRAN – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday...